Cancer Treatment Centers of America® and the National Football League Alumni Association have built a new partnership to raise awareness among NFL Alumni, and fans around the country about screening, diagnosis and treatment for prostate cancer. The partnership calls for CTCA to treat NFL Alumni Player Members who are fighting the disease at each of its five hospitals (in Atlanta, Chicago, Philadelphia, Phoenix and Tulsa). Certain restrictions apply. Other than non-melanoma skin cancer, prostate cancer is the most common cancer among men in the U.S. Nearly one in seven men will be diagnosed with prostate cancer in their lifetime. The American Cancer Society estimates that 233,000 new cases of prostate cancer were diagnosed in the U.S. in 2014. More than 29,000 men succumbed to the disease that year. “Routine screening has significantly improved the outlook for men with prostate cancer, which is very treatable when diagnosed early. And innovative technology has helped minimize the side effects of treatment,” says Maurie Markman, MD, President of Medicine and Science at CTCA. “We at CTCA are looking forward to working with the NFLA to bring a broader awareness of the latest clinical advances in prostate cancer treatment and deliver those to their membership.”
